Arrowhead Pharmaceuticals Stock News & Updates

[WKN: A2AGYB | Symbol: ARWR]

Arrowhead Pharmaceuticals: Study Success in Severe Hypertriglyceridemia Triggers Nearly 20% Stock Surge!

Plozasiran lowers triglycerides by up to 81% in phase 3 studies and reduces acute pancreatitis events....

TOP-5 Price Targets of Analysts on July 14, 2026

nVent Electric [IE00BDVJJQ56] Clear Street initiates coverage with "Buy" and a price target of 250...

Arrowhead Pharma: EU Approval for REDEMPLO Triggers Massive Volume

The European Commission grants formal market authorization for REDEMPLO, which as the only therapy...

Arrowhead Pharmaceuticals: Morgan Stanley upgrades to Overweight with target of $100 - Focus on price increase above resistance line

Arrowhead Pharmaceuticals (ARWR) is developing medications based on RNA interference (RNAi). This technology...

Analysts' Top 5 Price Targets of April 21, 2026

Uber Technologies [US90353T1007] TD Cowen maintains Buy rating with a price target of $114 (47% upside...

Stocks in Action USA: Microchip Technology, Zeta Global, Arrowhead Pharmaceuticals

Microchip Technology (MCHP) – Turnaround in the Chip Sector: Revenue Guidance Raised Thanks to Strong...

The Current Top 5 Price Rockets from the Largest Megatrends of 2025

For my last article in this column for the calendar year 2025, I took another look at the three megatrends...

Arrowhead Pharmaceuticals - Pharma Company Impresses with a Strong Pipeline!

Business drivers: Arrowhead Pharmaceuticals (ARWR) has focused on the development and commercialization...